Coexistence of allergic rhinitis and asthma in Indian patients: The CARAS survey.
Allergic rhinitis
CARAS
India
asthma
intranasal corticosteroids
prevalence
Journal
Lung India : official organ of Indian Chest Society
ISSN: 0970-2113
Titre abrégé: Lung India
Pays: India
ID NLM: 8405380
Informations de publication
Date de publication:
Historique:
entrez:
30
8
2019
pubmed:
30
8
2019
medline:
30
8
2019
Statut:
ppublish
Résumé
Asthma patients often suffer from concomitant allergic rhinitis (AR). However, there is paucity of such data from India. This questionnaire-based survey evaluated the coexistence of AR in Indian asthmatics, and examined the inter-relationship between the two disease conditions. This survey conducted in ten cities across India, aimed to generate information on exposure to risk factors, history of atopy, the severity of asthma, and treatment regimen in patients with physician-diagnosed asthma. Data were obtained from 1161 asthma patients (mean age [±standard deviation]: 40.41 [±17.05] years). Prevalence of coexisting AR was found to be 65.24%, with the highest prevalence (80%) in the southern regions of India. Sneezing (71.78%) followed by watery, runny nose (63.59%) were the most common AR symptoms. Majority (72.32%) of the patients had seasonal AR. Coexistence of AR and asthma was significantly associated with the presence of personal and family history of atopy (odds ratio 2.53 and 1.51 respectively; both P < 0.005). Passive smoking, exposure to biomass fuel, and the presence of pets and animals at home were also significantly (P < 0.005) associated with AR-asthma coexistence. Prevalence of AR was found to increase with increasing asthma severity. The usage of oral steroids was significantly higher in patients with coexistent AR-asthma. Sixty-six percent of the patients with coexistent AR-asthma were prescribed intranasal corticosteroids. The results of the Coexistence of Allergic Rhinitis and ASthma (CARAS) survey highlight the high prevalence of concomitant AR in Indian patients with asthma, and reinforce the need for early diagnosis and guideline-based management of AR in patients with asthma.
Identifiants
pubmed: 31464213
pii: LungIndia_2019_36_5_411_265182
doi: 10.4103/lungindia.lungindia_491_18
pmc: PMC6710977
doi:
Types de publication
Journal Article
Langues
eng
Pagination
411-416Déclaration de conflit d'intérêts
None
Références
J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):301-4
pubmed: 10452748
Respir Med. 2001 Jan;95(1):9-12
pubmed: 11207024
Am J Respir Crit Care Med. 2001 Apr;163(5):1108-12
pubmed: 11316644
Ann Allergy Asthma Immunol. 2002 Apr;88(4 Suppl 1):8-15
pubmed: 11991549
Indian J Chest Dis Allied Sci. 2003 Jul-Sep;45(3):179-89
pubmed: 12866635
J Asthma. 2004;41(3):311-7
pubmed: 15260464
J Asthma. 2006 Jan-Feb;43(1):1-7
pubmed: 16448958
J Asthma. 2006 Mar;43(2):165-7
pubmed: 16517435
BMC Pulm Med. 2006 Nov 30;6 Suppl 1:S3
pubmed: 17140421
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
Allergy. 2008 May;63(5):564-9
pubmed: 18394130
J Investig Allergol Clin Immunol. 2008;18(4):233-8
pubmed: 18714529
Asian Pac J Allergy Immunol. 2009 Mar;27(1):71-7
pubmed: 19548632
J Microbiol Immunol Infect. 2011 Apr;44(2):139-43
pubmed: 21439517
Prim Care Respir J. 2012 Jun;21(2):222-8
pubmed: 22643359
Am J Rhinol Allergy. 2012 May-Jun;26(3):187-90
pubmed: 22643942
Indian J Otolaryngol Head Neck Surg. 2009 Mar;61(1):5-8
pubmed: 23120594
Indian J Otolaryngol Head Neck Surg. 2015 Jun;67(2):143-9
pubmed: 26075169
J Asthma Allergy. 2016 May 11;9:93-100
pubmed: 27257389
Asthma Res Pract. 2015 Sep 7;1:8
pubmed: 27965762
Allergy Proc. 1994 Jan-Feb;15(1):21-5
pubmed: 8005452
Clin Exp Allergy. 1997 Jan;27(1):52-9
pubmed: 9117881
Lancet. 1998 Apr 25;351(9111):1225-32
pubmed: 9643741